Frankfurt · Stocky rates: Cautious

Aelis Farma S.A.S. A (69O.F)

€1.00 ▲ +1.94% as of 6 Aug, 23:10

Stocky turns companies like Aelis Farma S.A.S. A into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
49
/ 100
Neutral

What Stocky thinks

Cautious. Leadership Alignment at 45/100 suggests misalignment between insider incentives and shareholder interests—likely due to dilutive capital structures or weak founder-CEO tie. Without assessed vulnerabilities or visible moat, the risk-reward remains unfavorable until governance improves or a clear competitive advantage emerges.

Compounder Score
50/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
45/100
Founder-led, insider ownership, capital allocation history.

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Aelis Farma S.A.S. A:

49
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 49/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

45
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Aelis Farma S.A.S. A (69O.F) — frequently asked

Is Aelis Farma S.A.S. A (69O.F) a good investment right now?

Stocky rates Aelis Farma S.A.S. A (69O.F) at 49/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Leadership Alignment at 45/100 suggests misalignment between insider incentives and shareholder interests—likely due to dilutive capital structures or weak founder-CEO tie. Without assessed vulnerabilities or visible moat, the ris

What is 69O.F's Stocky Verdict?

69O.F's current Stocky Verdict is 49/100, placing it in the "Cautious" band. This composite combines a 50/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.

Does Aelis Farma S.A.S. A have a competitive moat?

Stocky hasn't finalised a Moat Score for Aelis Farma S.A.S. A yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Aelis Farma S.A.S. A's leadership aligned with shareholders?

Aelis Farma S.A.S. A scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to 69O.F?

Vulnerability Profile for Aelis Farma S.A.S. A covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.

This is just the surface. See the whole picture on Aelis Farma S.A.S. A.

Sign up free and unlock the full analysis on 69O.F — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 69O.F — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 69O.F.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 69O.F changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 69O.F?" · "Is 69O.F overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
49
/ 100 · Neutral

See Aelis Farma S.A.S. A the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in 69O.F would be worth today.
Practice portfolio
Buy 69O.F with virtual money and track it — zero risk.
Free · no real money · learn by doing Open 69O.F in Stocky →

Or jump straight to the interactive dashboard for 69O.F in the app.